Patents by Inventor Vincent Georges Verlant

Vincent Georges Verlant has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CHLAMYDIA VACCINES
    Publication number: 20080102112
    Abstract: Vaccine preparations are provided for the prevention of Chlamydia infections comprising a major outer membrane protein from chlamydia and a mucosal adjuvant such as a combination of QS21 and 3D-MPL, or chlorea Toxin or Heat labile enterotoxin. Such preparations provide protection from Chlamydia induced fertility.
    Type: Application
    Filed: October 29, 2007
    Publication date: May 1, 2008
    Inventors: Jean-Francois MAISONNEUVE, Jean-Paul Prieels, Moncef-Mohamed Slaoui, Vincent Georges Verlant
  • Vaccine composition
    Publication number: 20050281847
    Abstract: The present invention relates to the field of Gram-negative bacterial vaccine compositions, their manufacture, and the use of such compositions in medicine. More particularly it relates to the field of useful Gram-negative bacterial outer membrane vesicle (or bleb) compositions comprising heterologously expressed Chlamydia antigens, and advantageous methods of rendering these compositions more effective and safer as a vaccine.
    Type: Application
    Filed: April 12, 2005
    Publication date: December 22, 2005
    Inventors: Francois-Xavier Berthet, Yves Lobet, Jan Poolman, Vincent Georges Verlant